Patent · US Active

Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis

US10568867B2 · kind B2 · utility

0Cited by

3References

13Claims

0Family size

Assignee

Galapagos NV · BE

Inventors

Steven Emiel Van der Plas · Mechelen, BE
Hans Kelgtermans · Mechelen, BE
Sébastien Jean Jacques Cédric Dropsit Montovert · Mechelen, BE
Sébastien Laurent Xavier Martina · Mechelen, BE
Martin James Inglis Andrews · Mechelen, BE

Key dates

Filing date	Jan 9, 2018
Grant date	Feb 25, 2020
Priority date	—
Expiry date	Jan 9, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/6561
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention discloses compounds according to Formula I: wherein R1 is as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment cystic fibrosis by administering a compound of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.